A phase I study of carboplatin, paclitaxel and vinorelbine alternating with cisplatin and topotecan in patients with advanced ovarian cancer and peritoneal cancer

Trial Profile

A phase I study of carboplatin, paclitaxel and vinorelbine alternating with cisplatin and topotecan in patients with advanced ovarian cancer and peritoneal cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Jun 2009

At a glance

  • Drugs Carboplatin; Cisplatin; Paclitaxel; Topotecan; Vinorelbine
  • Indications Ovarian cancer; Peritoneal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2009 Planned number of patients changed from 30 to 30.
    • 20 Jan 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top